FRANCISCO JAVIER
MICHEL DE LA ROSA
Ikertzailea 2022-(e)ra arte
Hospital Costa Del Sol
Marbella, EspañaHospital Costa Del Sol-ko ikertzaileekin lankidetzan egindako argitalpenak (2)
2023
-
First-Line Versus Second-Line Use of Reslizumab in Severe Uncontrolled Asthma
Journal of Investigational Allergology and Clinical Immunology
2018
-
Cost of hospitalizations due to exacerbation in patients with non-cystic fibrosis bronchiectasis
Respiration, Vol. 96, Núm. 5, pp. 406-416